See All Slides - tctmd.com

Slides

Presentation TCT 2012

Complex Coronary Intervention

Presenter: Marco Alcocer-Gamba

October 25, 2012

Presentation TCT 2012

SYNTAX SCORE II: An Improved Risk Score Based on Clinical and Angiographic Variables

Presenter: Vasim Farooq

October 25, 2012

Presentation TCT 2012

RESPECT: A Prospective, Randomized Trial of PFO Closure vs. Medical Therapy in Patients with Cryptogenic Stroke

Presenter: John Carroll

October 25, 2012

Presentation TCT 2012

For: Treating Bystander Disease in the Primary PCI Setting Increases Risk!

Presenter: Ran Kornowski

October 25, 2012

Presentation TCT 2012

Completed and Ongoing Clinical Trials

Presenter: Laura Mauri

October 25, 2012

Presentation TCT 2012

Proposals for New Short-Term DAPT Use Trials After DES

Presenter: Roxana Mehran

October 25, 2012

$Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!$

Presentation TCT 2012

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Gilles Montalescot

October 25, 2012

Presentation TCT 2012

Functional Assessment of Coronary Artery Stenosis After Coronary Artery Bypass Graft

Presenter: Ioannis (John) Kanakakis

October 25, 2012

Presentation TCT 2012

Percutaneous Mitral Valve Repair: Clipping the Wings to Make Them Fly

Presenter: Carmelo Grasso

October 25, 2012

Presentation TCT 2012

Cases 3 and 4: FFR in Multiple and Serial Stenoses

Presenter: Pim Tonino

October 25, 2012

Advertisement

Slides

Complex Coronary Intervention

SYNTAX SCORE II: An Improved Risk Score Based on Clinical and Angiographic Variables

RESPECT: A Prospective, Randomized Trial of PFO Closure vs. Medical Therapy in Patients with Cryptogenic Stroke

For: Treating Bystander Disease in the Primary PCI Setting Increases Risk!

Completed and Ongoing Clinical Trials

Proposals for New Short-Term DAPT Use Trials After DES

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Functional Assessment of Coronary Artery Stenosis After Coronary Artery Bypass Graft

Percutaneous Mitral Valve Repair: Clipping the Wings to Make Them Fly

Cases 3 and 4: FFR in Multiple and Serial Stenoses

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content